ARLINGTON, Tenn.--(BUSINESS WIRE)--Jan. 2, 2012--
Wright Medical Group, Inc. (NASDAQ: WMGI), a global orthopaedic medical
device company, announced today that it will be participating in the 30th
Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2012 at
the Westin St. Francis Hotel in San Francisco, CA. Robert Palmisano,
President and Chief Executive Officer, will present at 2:30 p.m. Pacific
Time.
A live audio webcast of the conference presentation, along with the
accompanying presentation materials, will be available on Wright’s
corporate website at www.wmt.com/corporate,
under the “Investor Info” link. The audio webcast will be archived on
this site following the conference. The accompanying presentation
materials will be archived under the “Latest Investor Presentation” link.
Wright Medical Group, Inc. is a global orthopaedic medical device
company and a leading provider of surgical solutions for the foot and
ankle market. The Company specializes in the design, manufacture and
marketing of devices and biologic products for extremity, hip and knee
repair and reconstruction. The Company has been in business for more
than 60 years and markets its products in over 60 countries worldwide.
For more information about Wright Medical, visit the Company’s website
at www.wmt.com.
The conference call and webcast may contain “forward-looking
statements” as defined under U.S. federal securities laws. These
statements reflect management’s current knowledge, assumptions, beliefs,
estimates, and expectations and express management’s current views of
future performance, results, and trends and may be identified by their
use of terms such as “anticipate,” “believe,” “could,” “estimate,”
“expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” and
other similar terms. Forward-looking statements are
subject to a number of risks and uncertainties that could cause our
actual results to materially differ from those described in the
forward-looking statements. Such risks and uncertainties
include the impact of Wright's settlement of the federal investigation
into Wright's consulting arrangements with orthopaedic surgeons relating
to its hip and knee products in the United States, including Wright's
compliance with a Deferred Prosecution Agreement through September 2012
and a Corporate Integrity Agreement through September 2015, and those
risks and uncertainties discussed in our filings with the Securities and
Exchange Commission (including those described in Item 1A of our Annual
Report on Form 10-K for the year ended December 31, 2010, under the
heading, “Risk Factors” and in Item 1A of Part II of our 10-Qs filed
during 2011), including demand for and market acceptance of our new and
existing products; future actions of governmental authorities and other
third parties; tax measures; business development and growth
opportunities; product quality or patient safety issues; products
liability claims; enforcement of our intellectual property rights; the
geographic and product mix impact on our sales; retention of sales
representatives and independent distributors; inventory reductions or
fluctuations in buying patterns by wholesalers or distributors; ability
to realize the anticipated benefits of restructuring initiatives; and
impact of the commercial and credit environment on us and our customers
and suppliers. Readers should not place undue reliance on
forward-looking statements.
Source: Wright Medical Group, Inc.
Wright Medical Group, Inc.
Julie D. Tracy, 901-290-5817
Sr.
Vice President, Chief Communications Officer
julie.tracy@wmt.com
